Cyclic helix B peptide inhibits ischemia reperfusion-induced renal fibrosis via the PI3K/Akt/FoxO3a pathway

Renal fibrosis is a main cause of end-stage renal disease. Clinically, there is no beneficial treatment that can effectively reverse the progressive loss of renal function. We recently synthesized a novel proteolysis-resistant cyclic helix B peptide (CHBP) that exhibits promising renoprotective effe...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Transl Med
Hoofdauteurs: Yang, Cheng, Cao, Ye, Zhang, Yi, Li, Long, Xu, Ming, Long, Yaqiu, Rong, Ruiming, Zhu, Tongyu
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2015
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4641348/
https://ncbi.nlm.nih.gov/pubmed/26554357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-015-0699-2
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items